Robert J Adelman's Net Worth
-$2.86 Million
Who is Robert J Adelman?
Robert J Adelman does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Volcano Corp, Checkmate Pharmaceuticals, Inc., ARYx Therapeutics, Inc., RayzeBio, Inc., CRYOCOR INC, Ventyx Biosciences, Inc., ALX ONCOLOGY HOLDINGS INC, Akero Therapeutics, Inc., Metacrine, Inc., IMPEL NEUROPHARMA INC, Elevation Oncology, Inc., PRECISION BIOSCIENCES INC, and Artiva Biotherapeutics, Inc..
SEC CIK
Robert J Adelman's CIK is 0001329161
Past Insider Trading and Trends
2020 was Robert J Adelman's most active year for acquiring shares with 4 total transactions. Robert J Adelman's most active month to acquire stocks was the month of June. 2020 was Robert J Adelman's most active year for disposing of shares, totalling 4 transactions. Robert J Adelman's most active month to dispose stocks was the month of August. 2020 saw Robert J Adelman paying a total of $3,047,000.00 for 3,140,298 shares, this is the most they've acquired in one year. In 2020 Robert J Adelman cashed out on 2,907,298 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Checkmate Pharmaceuticals, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.75% | -131.65K |
$10.45 | -$1,375,564.42 | 2.16M |
May 13 - May 16
| |||
Form 4
| -6.57% | -160.90K |
$10.39 | -$1,671,823.84 | 2.29M |
May 10 - May 12
| |||
Form 4
| -3.42% | -86.68K |
$10.37 | -$898,920.56 | 2.45M |
May 5 - May 9
| |||
Form 4
| -9.65% | -270.68K |
$10.38 | -$2,809,332.35 | 2.54M |
May 2 - May 4
| |||
Form 4
| -6.34% | -190.03K |
$10.38 | -$1,972,578.78 | 2.81M |
Apr 27 - Apr 29
| |||
Form 4
| -4.15% | -129.78K |
$10.39 | -$1,347,796.50 | 3M |
Apr 22 - Apr 26
| |||
Form 4
| -14.91% | -547.73K |
$10.41 | -$5,700,491.17 | 3.13M |
Apr 19 - Apr 21
| |||
Form 4
|
∞
| 3.67M |
$15.00 |
—
| 3.67M |
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RayzeBio, Inc. (RYZB) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.16M |
—
|
—
| 5.16M |
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ventyx Biosciences, Inc. (VTYX) Snapshot price: $2.0801
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
∞
| 4M |
$16.00 |
—
| 4M |
Oct 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akero Therapeutics, Inc. (AKRO) Snapshot price: $26.41
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.70% | -116.47K |
$34.40 | -$4,006,536.85 | 3.03M |
Jul 1 - Jul 6
| |||
Form 4
| -1.44% | -45.95K |
$23.76 | -$1,091,607.66 | 3.15M |
Mar 4 - Mar 6
| |||
Form 4
| -0.68% | -21.80K |
$22.63 | -$493,310.23 | 3.2M |
Feb 28 - Mar 3
| |||
Form 4
| -0.18% | -5.90K |
$22.80 | -$134,635.10 | 3.23M |
Feb 25 - Feb 27
| |||
Form 4
| -0.15% | -10.03K |
$27.07 | -$271,399.19 | 6.46M |
Feb 10 - Feb 12
| |||
Form 4
| -0.19% | -6.10K |
$27.03 | -$164,954.76 | 3.23M |
Feb 6
| |||
Form 4
| -2.48% | -82.34K |
$25.77 | -$2,121,726.32 | 3.24M |
Feb 4 - Feb 5
| |||
Form 4
| -12.95% | -494.00K |
$20.23 | -$9,993,620.00 | 3.32M |
Jan 13
| |||
Form 4
| -0.41% | -15.68K |
$19.86 | -$311,354.63 | 3.82M |
Jan 8
| |||
Form 4
| -1.88% | -73.22K |
$19.86 | -$1,454,529.98 | 3.83M |
Jan 6 - Jan 7
| |||
Form 4
| -0.90% | -35.50K |
$19.71 | -$699,721.20 | 3.91M |
Jan 2 - Jan 3
| |||
Form 4
| -0.36% | -14.32K |
$23.96 | -$343,258.90 | 3.94M |
Dec 31
| |||
Form 4
|
∞
| 3.95M |
$16.00 |
—
| 3.95M |
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMPEL NEUROPHARMA INC (IMPL) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.76M |
$15.00 |
—
| 2.76M |
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||